EGM
APGE

Engineers Gate Manager’s Apogee Therapeutics APGE Stock Holding History

Engineers Gate Manager’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84M Buy
+21,393
New +$1.93M 0.04% 537
2025
Q2 		– Sell
-5,988
Closed -$224K – 2138
2025
Q1 		$224K Buy
+5,988
New +$232K ﹤0.01% 1842

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Engineers Gate Manager's APGE Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 21,393 shares worth $2.84M. The stake represents 0.04% of the portfolio and ranks #537 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in APGE as recently as Q1 2025.

Engineers Gate Manager first reported a position in APGE in Q1 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Engineers Gate Manager held 21,393 shares of Apogee Therapeutics worth $2.84M as of Q2 2026.
  • Apogee Therapeutics was a new Engineers Gate Manager position in Q2 2026.
  • Apogee Therapeutics made up 0.04% of Engineers Gate Manager's portfolio in Q2 2026, its #537 holding.
  • Engineers Gate Manager first reported a position in Apogee Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.